This inventor holds 1 USPTO granted patent. Top assignee: Rhode Island Hospital. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kevin S Ernsting: Innovator in Non-Invasive Medical Technology
Introduction
Kevin S Ernsting is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of medical technology, particularly in non-invasive methods for determining blood components. His innovative approach has the potential to enhance patient care and streamline medical diagnostics.
Latest Patents
Kevin holds a patent for a method titled "Non-invasive determination of blood components." This patent describes a technique for estimating the amount of a substance in a bodily fluid by analyzing the color of a tissue surface. The method involves capturing a digital image that includes both the subject's tissue and a color reference. By obtaining values associated with the tissue and reference portions, the estimated amount of the substance can be calculated. This innovative approach could revolutionize how medical professionals assess blood components without invasive procedures.
Career Highlights
Kevin is currently affiliated with Rhode Island Hospital, where he applies his expertise in medical technology. His work focuses on developing non-invasive diagnostic methods that can improve patient outcomes. With a patent portfolio that includes one significant patent, Kevin is recognized for his contributions to the medical field.
Collaborations
Kevin has collaborated with esteemed colleagues such as Gregory D Jay and Selim Suner. These partnerships have fostered an environment of innovation and have contributed to the advancement of non-invasive medical technologies.
Conclusion
Kevin S Ernsting is a pioneering inventor whose work in non-invasive determination of blood components showcases his commitment to improving medical diagnostics. His innovative methods have the potential to transform patient care and enhance the accuracy of medical assessments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
